News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DelSite Biotechnologies, Inc. Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine



8/20/2008 11:26:30 AM

IRVING, Texas, Aug. 20, 2008 (GLOBE NEWSWIRE) (PRIME NEWSWIRE) -- DelSite Inc., (OTCBB:DSII) today announced DelSite Biotechnologies, Inc., its wholly-owned subsidiary, filed an Investigational New Drug (IND) application with the FDA for its lead product candidate GelVac(tm) nasal powder H5N1 influenza vaccine.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES